ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 189,36
0,71%
Dow Jones
39 239,73
0,47%
DAX
18 697,84
1,13%
Brent Oil
83,545
-0,02%
Bitcoin
62 052,97
1,41%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Alaunos Therapeutics Inc (TCRT)

  7. Alaunos Therapeutics Inc (TCRT) Actualités

TCRT

Alaunos Therapeutics (TCRT)

Alaunos Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TCRT
DateHeureSourceTitreSymboleSociété
29/02/202403h46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
22/02/202422h44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCRTAlaunos Therapeutics Inc
14/02/202418h43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCRTAlaunos Therapeutics Inc
23/01/202423h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
14/11/202313h30GlobeNewswire Inc.Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
01/09/202318h20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TCRTAlaunos Therapeutics Inc
14/08/202322h37Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCRTAlaunos Therapeutics Inc
14/08/202322h05GlobeNewswire Inc.Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic AlternativesNASDAQ:TCRTAlaunos Therapeutics Inc
29/06/202313h00GlobeNewswire Inc.Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic MalignanciesNASDAQ:TCRTAlaunos Therapeutics Inc
12/06/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCRTAlaunos Therapeutics Inc
08/06/202323h25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCRTAlaunos Therapeutics Inc
25/05/202323h00GlobeNewswire Inc.Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
10/05/202313h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TCRTAlaunos Therapeutics Inc
10/05/202313h00GlobeNewswire Inc.Alaunos Therapeutics Reports First Quarter 2023 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
03/05/202314h30GlobeNewswire Inc.Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023NASDAQ:TCRTAlaunos Therapeutics Inc
26/04/202318h30GlobeNewswire Inc.Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual MeetingNASDAQ:TCRTAlaunos Therapeutics Inc
25/04/202323h07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TCRTAlaunos Therapeutics Inc
19/04/202322h31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TCRTAlaunos Therapeutics Inc
14/04/202323h06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TCRTAlaunos Therapeutics Inc
30/03/202313h00GlobeNewswire Inc.Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of DirectorsNASDAQ:TCRTAlaunos Therapeutics Inc
29/03/202323h30GlobeNewswire Inc.Alaunos Therapeutics to Participate in Upcoming Investor Conferences in AprilNASDAQ:TCRTAlaunos Therapeutics Inc
07/03/202313h32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TCRTAlaunos Therapeutics Inc
07/03/202313h00GlobeNewswire Inc.Alaunos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
28/02/202322h01GlobeNewswire Inc.Alaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023NASDAQ:TCRTAlaunos Therapeutics Inc
14/02/202319h31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCRTAlaunos Therapeutics Inc
09/01/202314h30GlobeNewswire Inc.Alaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023NASDAQ:TCRTAlaunos Therapeutics Inc
29/11/202215h01GlobeNewswire Inc.Alaunos Therapeutics Announces Pricing of Public Offering of Common StockNASDAQ:TCRTAlaunos Therapeutics Inc
28/11/202222h01GlobeNewswire Inc.Alaunos Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:TCRTAlaunos Therapeutics Inc
15/11/202212h25TipRanksH.C. Wainwright Sticks to Their Hold Rating for Alaunos Therapeutics (TCRT)NASDAQ:TCRTAlaunos Therapeutics Inc
14/11/202213h00GlobeNewswire Inc.Alaunos Therapeutics Reports Third Quarter 2022 Financial ResultsNASDAQ:TCRTAlaunos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TCRT

Dernières Valeurs Consultées

EU
EN
Bouygues
SPI
SP500
S&P 500
NASDAQ
AMZN
Amazon.com
FTSE
UKX
FTSE 100
EU
HO
Thales
NYSE
KO
Coca Cola
EU
RI
Pernod Ricard
USI
USTECH100
US Tech 100
EU
ML
Michelin
EU
AF
Air FranceKLM
EU
DG
Vinci
NASDAQ
NVDA
NVIDIA
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés